MAPT and Alzheimer disease: Our findings suggest that OP’s neurodegenerative effects may be driven by elevated baseline CSF t-tau and p-tau levels, and the accelerated entorhinal cortex and hippocampal atrophy among older adults, providing critical insight into the neuropathological mechanisms by which OP increases the risk of developing AD.